Premium Iol denied for failing step therapy by Blue Cross Blue Shield?

Blue Cross Blue Shield's specific coverage criteria for premium iol are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why BCBS Denied Your Premium IOL Under Step Therapy — and How to Appeal

Step therapy (also called "fail-first") for a premium intraocular lens (IOL) typically means BCBS requires documented use of — or a clinical reason for bypassing — a standard monofocal IOL before it will cover a premium lens such as a multifocal, extended-depth-of-focus (EDOF), or toric design. Because cataract surgery is a single-episode event, the step-therapy framework can be clinically inappropriate when the monofocal option has never been tried and cannot be tried retroactively. This creates a strong basis for appeal.

## Why This Denial Is Appealable

Step-therapy rules must yield to medical necessity. When the structure of the procedure makes sequential "stepping" physically impossible — as is often the case with IOL selection at the time of cataract surgery — the plan cannot mechanically apply a step-therapy requirement without a medical-necessity exception pathway. Many states also have step-therapy protection laws requiring insurers to grant exceptions in defined clinical circumstances. Consult your state's insurance commissioner website or your employer's HR/benefits team to identify applicable protections.

## Your Federal Appeal Rights

• ACA §2719 / ERISA §503 — Non-grandfathered commercial and most employer-sponsored plans must provide internal appeal and independent external review.
• External review window — Typically approximately four months from the adverse determination date. Track this deadline.
• Expedited review — Available if a pending procedure is being delayed and delay poses clinical risk.

## Concrete Appeal Steps

1. Obtain the full clinical criteria — Request BCBS's current step-therapy protocol for IOLs in writing. Identify the exception criteria. 2. Document why stepping is not clinically feasible — Your ophthalmologist should explain in a letter why the standard lens cannot serve as a first step in your specific case (e.g., the surgical window has passed, the anatomical/refractive condition at issue is not addressable by a monofocal). 3. File Level 1 internal appeal — Include the prescriber letter, clinical notes, and a direct response to each step-therapy criterion. 4. Invoke state step-therapy protections if available — Cite the applicable state statute or regulation in your appeal letter. 5. Escalate to external review if BCBS upholds the denial.

## Documentation to Gather

• Ophthalmology consultation notes documenting the specific ocular condition, refractive error, or comorbidity that makes a premium lens clinically necessary.
• Explanation of why a standard monofocal IOL is clinically insufficient — in your prescriber's own words, tied to your chart findings.
• Prior treatment history relevant to the underlying ocular condition (prior refractive surgery, corneal pathology, etc.) that informs lens selection.
• BCBS step-therapy exception criteria — obtain the current policy document and map each criterion to a specific chart finding.
• State step-therapy law reference — if your state has enacted step-therapy protections, include a citation in the appeal.

## Criteria-Mapping Structure

List each step-therapy requirement and each exception criterion from the BCBS policy. For every item, write one sentence identifying the chart note, date, and physician statement that addresses it. Close with a paragraph explaining why, given these facts, continued application of the step-therapy requirement would be clinically unreasonable and inconsistent with the applicable BCBS exception standard.